Skip to main content
. 2018 Feb 12;98(4):1152–1158. doi: 10.4269/ajtmh.17-0637

Figure 3.

Figure 3.

(A and B) Soluble CD14 (sCD14) and tumor necrosis factor receptor 1 (TNFR1) plasma concentrations fell in the rifaximin group over 42 days.